Six independent proteomics studies show that CSF levels of clusterin are significantly increased in AD patients (see meta-analysis in Pedrero-Prieto et al., 2020); plasma levels also rise in ALS (Xu et al., 2018). Here, CLU is linked to amyotrophic lateral sclerosis.